1. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
   Liubing Hu et al, 2022, Frontiers in Oncology CrossRef
2. The Nursing Effect of Individualized Management on Patients With Diabetes Mellitus Type 2 and Hypertension
   Ran Li et al, 2022, Frontiers in Endocrinology CrossRef
3. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma
   Masaaki Ito et al, 2022, Esophagus CrossRef
4. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
   Masaaki Ito et al, 2021, Frontiers in Oncology CrossRef
5. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
   Shu-Yang Li et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
6. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
   Shu-Yang Li et al, 2021, Scientific Reports CrossRef
7. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
   Takaki Hiwasa et al, 2021, BMC Medicine CrossRef
8. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
   Toshiki Namiki et al, 2023, BMC Endocrine Disorders CrossRef
9. Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma
   Masaaki Ito et al, 2024, Cancer Science CrossRef